Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Goldline Pharmaceutical Ltd has notified BSE that its trading window will remain closed from 19th May 2026 for all designated persons and their immediate relatives. The closure is pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, and applies until 48 hours after the declaration of audited financial results for the half year and year ended 31st March 2026. The company plans to hold a board meeting to consider these financial results, with the date to be announced separately. This is a standard compliance measure to prevent insider trading ahead of material financial disclosures.
No direct impact on the stock price. This is routine compliance. However, investors should note that the share price may experience volatility once the financial results are announced and the trading window reopens.